Page last updated: 2024-11-08

polygalacturonic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

galacturonic acid: N1 same as NM; RN given refers to parent cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

D-galactopyranuronic acid : The pyranose form of D-galacturonic acid [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

D-galacturonic acid : The D-enantiomer of galacturonic acid. It is the main component of pectin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439215
CHEBI ID4153
CHEBI ID18024
CHEBI ID33830
SCHEMBL ID24470
MeSH IDM0044159

Synonyms (33)

Synonym
galacturonic acid
d-galacturonic acid
d-galactopyranuronic acid
C00333 ,
D-GALACTURONATE ,
CHEBI:4153 ,
25990-10-7
BMSE000216
37331-21-8
9046-38-2
(2s,3r,4s,5r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid
AKOS006283705
d-galactopyranuronate ,
SCHEMBL24470
galacturonicacid
552-12-5
galactopyranuronate
GALA ,
galacuronate
galactopyranuronic acid
d-gala
mfcd00131972
F20755
Q27106309
DTXSID001015577 ,
(2s,3r,4s,5r)-3,4,5,6-tetrahydroxytetrahydro-2h-pyran-2-carboxylic acid
EN300-19632874
802566-71-8
d-galacturonic acids
dtxcid001473828
dtxcid0022646
chebi:18024
chebi:33830

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"Sulfuric acid hydrolysis according to the Saeman procedure, TFA hydrolysis, and methanolysis combined with TFA hydrolysis were compared for the hydrolysis of water-soluble uronic acid-containing polysaccharides originating from fungi, plants, and animals."( Carbohydrate analysis of water-soluble uronic acid-containing polysaccharides with high-performance anion-exchange chromatography using methanolysis combined with TFA hydrolysis is superior to four other methods.
De Ruiter, GA; Rombouts, FM; Schols, HA; Voragen, AG, 1992
)
0.28

Bioavailability

ExcerptReferenceRelevance
" Metal oligo/polygalacturonate mixed complexes contain all deficient essential metal ions in adequate amounts and ratios for higher bioavailability of metal ions and optimal vital function."( [The role of essential metal ions in the human organism and their oral supplementation to the human body in deficiency states].
Balla, G; Balla, J; Lakatos, B; Szentmihályi, K; Vinkler, P, 2004
)
0.32
" ficus-indica cladodes may retain material tightly associated with cell-wall components, and this property will have the potential to greatly reduce the bioavailability of bioactive compounds."( Anatomical, chemical, and biochemical characterization of cladodes from prickly pear [Opuntia ficus-indica (L.) Mill.].
Bennett, RN; Bisignano, G; Faulds, CB; Ginestra, G; Lo Curto, RB; Mandalari, G; Narbad, A; Parker, ML; Robertson, J; Waldron, KW, 2009
)
0.35
" The EPS was used to amend natural seawater to investigate the bioavailability of this EPS by native populations, in the presence and absence of ammonium and phosphate amendment."( The Fate of Marine Bacterial Exopolysaccharide in Natural Marine Microbial Communities.
Cai, R; Chen, Y; Fu, Y; Jiao, N; Wang, R; Zhang, Z, 2015
)
0.42
" The low molecular weight of MTrPP (155kDa; TrPP-13kDa) may increase its bioavailability than TrPP, thus MTrPP may possess higher antiulcer potential."( Modified pectic polysaccharide from turmeric (Curcuma longa): A potent dietary component against gastric ulcer.
Chandra Prakash, SV; Dharmesh, SM; Harsha, MR, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
"05, dosage of 200 mg/kgd body weight) in peripheral lymphocytes compared to the irradiated control."( Water-soluble polysaccharides from Angelica sinensis (Oliv.) Diels: Preparation, characterization and bioactivity.
Gu, X; Li, D; Sun, Y; Tang, J, 2005
)
0.33
" In vitro experiment, the results showed that RAPS at dosage of 15."( Structure characterization of three polysaccharides and a comparative study of their immunomodulatory activities on chicken macrophage.
Fan, W; Hao, P; Liu, J; Zhang, S; Zhao, X; Zheng, P, 2016
)
0.43
"Honey-processed Astragalus is a dosage form of Radix Astragali processed with honey, which exhibits better efficacy of tonifying Qi than the raw product."( Structural differences of polysaccharides from Astragalus before and after honey processing and their effects on colitis mice.
Bai, L; Bo, R; Chen, H; Huang, L; Li, C; Rui, W; Wu, J; Ye, M, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
D-galacturonic acidThe D-enantiomer of galacturonic acid. It is the main component of pectin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
UDP-u03B1-D-galacturonate biosynthesis II (from D-galacturonate)29
homogalacturonan degradation03
L-ascorbate biosynthesis VII (plants, D-galacturonate pathway)09
superpathway of microbial D-galacturonate and D-glucuronate degradation3592
pectin degradation II37
pectin degradation I311
UDP-u03B1-D-galacturonate biosynthesis II (from D-galacturonate)09
L-ascorbate biosynthesis V127
D-galacturonate degradation III612
UDP-D-galacturonate biosynthesis II (from D-galacturonate)29
pectin degradation III48

Research

Studies (540)

TimeframeStudies, This Drug (%)All Drugs %
pre-199059 (10.93)18.7374
1990's77 (14.26)18.2507
2000's144 (26.67)29.6817
2010's186 (34.44)24.3611
2020's74 (13.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.47 (24.57)
Research Supply Index6.31 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index49.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other540 (98.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]